Haleon
Haleon (LSE: HLN) is a global leader in consumer health, with brands trusted by millions of consumers globally. The group employs over 24,000 people across 170 markets, who are united by Haleon’s purpose - to deliver better everyday health with humanity.
Haleon’s product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, Parodontax and Centrum - are built on trusted science, innovation and deep human understanding. Haleon operates in 46 markets across the MEA region, with key hubs located in the Kingdom of Saudi Arabia, the Gulf and Near East, South Africa, Sub-Saharan Africa, Pakistan, North Africa (including Egypt and others), and Turkey.
Haleon is also committed to empower millions of people in the region and around the world toward effective self-care practices and maximize the positive outcomes that self-care can bring.